• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Exicure, Inc.

Exicure, Inc. Receives Extension from Nasdaq Hearings Panel
September 18, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation
September 09, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces 1-for-5 Reverse Stock Split
August 26, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
August 19, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
August 15, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Second Quarter 2024 Financial Results
August 13, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
August 08, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Receives Positive Listing Determination from Nasdaq
August 01, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports First Quarter 2024 Financial Results
June 17, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Full Year 2023 Financial Results
June 06, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Received Nasdaq Notice of a Delisting Determination
May 23, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Third Quarter 2023 Financial Results
May 16, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
April 22, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
February 05, 2024
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
November 28, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
August 23, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
July 14, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
May 26, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
May 19, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
May 04, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
April 27, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
March 27, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
February 24, 2023
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
December 14, 2022
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
September 26, 2022
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
September 01, 2022
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
August 15, 2022
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 20, 2022
From Exicure, Inc.
Via Business Wire
Tickers XCUR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap